GREAT NEWS: VACCINE DOSES PLENTIFUL AT CHRISTUS GOOD SHEPHERD-LONGVIEW AND NEED TO BE ADMINISTERED PRONTO. IT IS NOW VERY EASY TO SIGN UP. VACCINE APPOINTMENTS AVAILABLE — SIGN UP NOW (click this)
Good computer help available to schedule. Phone number available. If we don’t use this vaccine, we might not get more. Call your friends and family and employees — here or nearby. We need to use this vaccine.
MORE GREAT NEWS FOR PATIENTS ON ACE INHIBITOR DRUG FOR HIGH BLOOD PRESSURE
The study’s findings suggest that ACEIs and ARBs may be associated with protective benefits for patients with COVID-19 and that patients may continue receiving ACEIs and ARBs for the treatment of any condition without an increased risk of worse outcomes unless specifically advised to avoid them by treating clinicians….Conclusions and Relevance In this systematic review and meta-analysis, receipt of ACEIs or ARBs was not associated with a higher risk of multivariable-adjusted mortality and severe AEs among patients with COVID-19 who had either hypertension or multiple comorbidities, supporting the recommendations of medical societies. On the contrary, ACEIs and ARBs may be associated with protective benefits, particularly among patients with hypertension. Future randomized clinical trials are warranted to establish causality.
(J. Harris: A year ago we looked at some suggestions and undocumented theories that this common group of drugs might make infections with Covid more common or more serious. There were no studies proving this, and, since this group of drugs contains some of the very best and most commonly used and inexpensive drugs for BP control, several good doctors (and I ) recommended patients should continue their medications until scientific studies were reported in the medical literature regarding the drugs or until their personal MD (where they still exist) tell their patients to stop taking the drugs. WELL, THE DRUGS ARE NOT ONLY SAFE, THEY MAY BE PROTECTIVE! THIS IS WHY SCIENTIFIC RESEARCH IS DONE. KEEP TAKING THESE DRUGS UNLESS YOU DOCTOR TELLS YOU DIFFERENTLY:
From the NYT:
“…The researchers suspect that the first dose produces a broad range of antibodies that can stick to spots along the length of the spike protein, and that the second dose delivers a big supply of particularly potent antibodies to the tip of the spike. Together, the assortment of antibodies does a better job of stopping the coronavirus…As the number of authorized vaccines grows, the possible combinations in which they can be used will explode…As the number of authorized vaccines grows, the possible combinations in which they can be used will explode.”
(J. Harris: There has been some success with other infections doing this “mix and match.”)
FROM BECKER’S CITATIONS:
Low levels of flu activity amid the COVID-19 pandemic have made it more challenging for experts developing next year’s flu shot to predict which strains will predominate next winter….Without a strong enough vaccine, the U.S. could experience a severe flu season.
FROM THE NYT:
LAST NOT LEASED:
GIVE US YOUR FEEDBACK. CLICK ON “COMMENT” TO TELL US WHAT YOU THINK or use one of the alternative methods for providing feedback.